Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

Trial Identifier:	D5290C00007
Sponsor:	AstraZeneca
Collaborator:	IQVIA RDS (Shanghai) Co., Ltd.
NCTID::	NCT04840849
Start Date:	June 2021
Primary Completion Date:	November 2021
Study Completion Date:	November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Chinese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Shanghai, CN, 200040

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.